Aqr Capital Management LLC Geron Corp Transaction History

Aqr Capital Management LLC

$75.6 Billion
Q4 2024

A detailed history of Aqr Capital Management LLC transactions in Geron Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 251,761 shares of GERN stock, worth $402,817. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,761

Previous 226,742 11.03%

Holding current value

$402,817

Previous $1.03 Million 13.41%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.3 - $4.44 $82,562 - $111,084	25,019 Added 11.03%	251,761 $891,000
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $773,522 - $925,630	185,497 Added 449.74%	226,742 $1.03 Million
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $127,859 - $209,937	41,245 New	41,245 $174,000
Q4 2023 Feb 14, 2024	SELL	$1.74 - $2.31 $82,202 - $109,131	-47,243 Reduced 61.17%	29,992 $63,000
Q3 2023 Nov 14, 2023	SELL	$2.11 - $3.28 $74,905 - $116,440	-35,500 Reduced 31.49%	77,235 $163,000
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $1,914 - $3,586	972 Added 0.87%	112,735 $361,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $55,560 - $88,274	25,963 Added 30.26%	111,763 $242,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $55,079 - $65,661	27,133 Added 46.25%	85,800 $207,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $97,973 - $172,480	58,667 New	58,667 $137,000
Q1 2021 May 17, 2021	SELL	$1.52 - $2.1 $81,408 - $112,471	-53,558 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.59 - $2.19 $85,157 - $117,292	53,558 New	53,558 $93,000
Q1 2019 May 14, 2019	SELL	$1.01 - $1.83 $101,588 - $184,066	-100,583 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$1.76 - $6.38 $33,432 - $121,194	18,996 Added 23.28%	100,583 $177,000
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $268,421 - $393,249	81,587 New	81,587 $280,000

Others Institutions Holding GERN

# of Institutions

306

Shares Held

465M

Call Options Held

1.07M

Put Options Held

648K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $605M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Geron Corp Transaction History